ITGB4 and cancer: The association of ITGB4 with poor prognosis in many cancers is attributed to the ability of integrin α6β4 to promote malignant behaviours, such as proliferative signaling, the evasion of apoptosis, tissue invasion and metastasis, and the induction of angiogenesis.